⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Global Experts call for Paradigm Shift in Medicine, Health and Education to Save Lives and Fight Escalating Health Crisis
accessnewswire.com
BMY
MRK
PFE
JNJ
ABBV
AMGN
GILD
REGN
BIIB
LLY
Complement Inhibitors Market Outlook Remains Strong During the Forecast Period (2026–2036) with Increasing Adoption of C5 and C3 Targeted Drugs | DelveInsight
globenewswire.com
AZN
IONS
ARWR
REGN
SNY
OMER
La expansión de ESTEVE en EU y EEUU impulsa crecimiento y consolidación como farmacéutica global USA - español USA - English Portugal - Português
prnewswire.com
REGN
ESTEVE'S EXPANSION AND GROWTH IN EU AND USA ACCELERATES ITS TRANSFORMATION INTO A GLOBAL HEALTHCARE COMPANY
prnewswire.com
REGN
The Power of Community to Improve Asthma and Allergy Health
globenewswire.com
AMGN
GNE
SNY
REGN
Form 8-K
sec.gov
REGN
Regeneron Reports First Quarter 2026 Financial and Operating Results
globenewswire.com
REGN
Rheumatoid Arthritis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the Therapeutics Landscape
globenewswire.com
UCB
AZN
LLY
PFE
ABBV
REGN
AMGN
BMY
SNY
JNJ
TLRY
Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipeline
globenewswire.com
GLPG
REGN
Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight
globenewswire.com
MRK
IPHA
VERU
KURA
INCY
AMGN
PFE
GILD
REGN
AZN
CRSP
BIIB
NTRA
ALLO
KYMR
ADCT
IMUX
CELC
ONON
ABBV
TDOC
BMY
IMVT
GNTX
IMPP
AUTL